Literature DB >> 7969043

Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression.

G Nickenig1, T J Murphy.   

Abstract

The effects of epidermal growth factor, basic fibroblast growth factor, and platelet-derived growth factor-BB on angiotensin type 1 (AT1) receptor gene expression were examined in rat thoracic aorta vascular smooth muscle cells (VSMC) in culture. Incubation of serum-deprived VSMC with 20 ng/ml epidermal growth factor, 20 ng/ml basic fibroblast growth factor, or 50 ng/ml platelet-derived growth factor-BB reduces AT1 receptor mRNA levels, as assessed by Northern hybridization analysis, to approximately 30% of control levels. This effect is maximal 4 hr after addition of each growth factor to the culture medium and is sustained for up to 24 hr of incubation after a single dose. There is a correlative loss of membrane-associated AT1 receptors and angiotensin II-stimulated inositol phosphate production after 24 hr of growth factor treatment. The half-life of AT1 receptor mRNA is reduced significantly by growth factors, compared with that for cells treated with actinomycin D alone to block transcription. This suggests that growth factors activate a mechanism that involves post-transcriptional destabilization of AT1 receptor mRNA. This effect can be blocked by prior treatment of VSMC with actinomycin D or cycloheximide, suggesting that the effect of the growth factors on AT1 receptor gene expression is mediated through induction of an unknown gene or genes that function to destabilize AT1 receptor mRNA and that mRNA translation is essential for the destabilizing effect. Nuclear run-on assays reveal that the growth factors also significantly reduce the rate of de novo AT1 receptor gene transcription. Thus, down-regulation of AT1 receptor gene expression by growth factors also appears to involve mechanisms that decrease the rate of AT1 receptor gene transcription. These data reveal marked down-regulation of AT1 receptor gene expression in VSMC by growth factor receptor activation, through mechanisms that involve both attenuation of transcription and post-transcriptional mRNA destabilization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969043

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  The inducible cAMP early repressor ICERIIgamma inhibits CREB and AP-1 transcription but not AT1 receptor gene expression in vascular smooth muscle cells.

Authors:  X Wang; T J Murphy
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 2.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

3.  Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH.

Authors:  Marina C Muñoz; Valeria Burghi; Johanna G Miquet; Jorge F Giani; Ricardo D Banegas; Jorge E Toblli; Yimin Fang; Feiya Wang; Andrzej Bartke; Fernando P Dominici
Journal:  J Endocrinol       Date:  2014-04-22       Impact factor: 4.286

Review 4.  Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis.

Authors:  Thomas A Morinelli; Louis M Luttrell; Erik G Strungs; Michael E Ullian
Journal:  Int J Biochem Cell Biol       Date:  2016-05-07       Impact factor: 5.085

5.  Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression.

Authors:  G Nickenig; K Strehlow; A T Bäumer; S Baudler; S Wassmann; H Sauer; M Böhm
Journal:  Br J Pharmacol       Date:  2000-10       Impact factor: 8.739

6.  Regulation of AT1R expression through HuR by insulin.

Authors:  Kirsi Paukku; Michael Backlund; Rudolf A De Boer; Nisse Kalkkinen; Kimmo K Kontula; Jukka Y A Lehtonen
Journal:  Nucleic Acids Res       Date:  2012-02-23       Impact factor: 16.971

7.  Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells.

Authors:  Guanghong Jia; Anshu Aggarwal; Amanuel Yohannes; Deepak M Gangahar; Devendra K Agrawal
Journal:  J Cell Mol Med       Date:  2011-08       Impact factor: 5.310

8.  Posttranscriptional regulation of angiotensin II type 1 receptor expression by glyceraldehyde 3-phosphate dehydrogenase.

Authors:  Michael Backlund; Kirsi Paukku; Laurent Daviet; Rudolf A De Boer; Erkka Valo; Sampsa Hautaniemi; Nisse Kalkkinen; Afshin Ehsan; Kimmo K Kontula; Jukka Y A Lehtonen
Journal:  Nucleic Acids Res       Date:  2009-02-26       Impact factor: 16.971

9.  p100 increases AT1R expression through interaction with AT1R 3'-UTR.

Authors:  Kirsi Paukku; Nisse Kalkkinen; Olli Silvennoinen; Kimmo K Kontula; Jukka Y A Lehtonen
Journal:  Nucleic Acids Res       Date:  2008-07-04       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.